Skip to main content
Clinical Trials/NCT05160870
NCT05160870
Recruiting
Not Applicable

Genotype-phenotype Correlation and Pathogenic Mechanism in Hereditary Ataxia

Second Affiliated Hospital, School of Medicine, Zhejiang University1 site in 1 country500 target enrollmentJune 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hereditary Ataxia
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
500
Locations
1
Primary Endpoint
Serum neurofilament light chain
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The investigators aimed to find appropriate biomarkers such as serum neurofilament light chain in reflecting disease severity in hereditary ataxia from a large cohort during long-term follow-up. The disease severity is indicated by clinical scales and brain MRI tests.

Registry
clinicaltrials.gov
Start Date
June 30, 2021
End Date
December 25, 2025
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • genetically diagnosed as Spinocerebellar ataxia

Exclusion Criteria

  • deny follow-yp

Outcomes

Primary Outcomes

Serum neurofilament light chain

Time Frame: from 2021 to 2025

Serum neurofilament light chain levels were collected among patients in preclinical or mild stage of Spinocerebellar ataxia, especially type 3.

Study Sites (1)

Loading locations...

Similar Trials